| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Addendum 6: A few key elements in the design and interpretation of pharmaco-epidemiological studies
|
|
|
2013
|
|
2-3 |
p. 251-261
|
article
|
| 2 |
Addendum 4: British guidelines for “postmarketing surveillance studies”
|
|
|
2013
|
|
2-3 |
p. 239-241
|
article
|
| 3 |
Addendum 7: Glossary and abbreviations
|
|
|
2013
|
|
2-3 |
p. 263-270
|
article
|
| 4 |
Addendum 1: Health authorities' ADE reporting forms
|
|
|
2013
|
|
2-3 |
p. 223-225
|
article
|
| 5 |
Addendum 2: Reporting ADEs to health authorities
|
|
|
2013
|
|
2-3 |
p. 227-230
|
article
|
| 6 |
Addendum 3: Screening ADE databases
|
|
|
2013
|
|
2-3 |
p. 231-237
|
article
|
| 7 |
Addendum 5: Useful databases
|
|
|
2013
|
|
2-3 |
p. 243-250
|
article
|
| 8 |
Analysis of the information in a central ADE database
|
|
|
2013
|
|
2-3 |
p. 105-123
|
article
|
| 9 |
A presentation of compulsory licensing
|
James Love
|
|
2001
|
|
2-3 |
p. 153-161
|
article
|
| 10 |
Book reviews
|
|
|
2001
|
|
2-3 |
p. 187-190
|
article
|
| 11 |
Britain's rising caesarean rate: Time to take action
|
Tara Kaufmann
|
|
2001
|
|
2-3 |
p. 103-107
|
article
|
| 12 |
Causality assessment of individual ADEs
|
|
|
2013
|
|
2-3 |
p. 125-144
|
article
|
| 13 |
Concerns about the use of buspirone in Alzheimer patients
|
Ian Williams Goddard
|
|
2001
|
|
2-3 |
p. 91-94
|
article
|
| 14 |
Consumer reports on medicines?–?CRM: Policy and Practice
|
|
|
2001
|
|
2-3 |
p. 117-127
|
article
|
| 15 |
Dying of market failure
|
Ellen 't Hoen
|
|
2001
|
|
2-3 |
p. 137-142
|
article
|
| 16 |
Early failure and mortality following intramedullary fixation of peritrochanteric fractures
|
N. Levi
|
|
2001
|
|
2-3 |
p. 99-101
|
article
|
| 17 |
East Timor: Building health in a vacuum
|
|
|
2001
|
|
2-3 |
p. 177-178
|
article
|
| 18 |
Electrical safety in patient care areas
|
Cislo, Ray
|
|
2013
|
|
2-3 |
p. 157-159
|
article
|
| 19 |
Estimating the frequency of adverse drug effects from spontaneous ADE reports
|
|
|
2013
|
|
2-3 |
p. 145-166
|
article
|
| 20 |
Extra-hospital dialysis: the patient is at risk, not the method
|
Viron, B.
|
|
2013
|
|
2-3 |
p. 145-155
|
article
|
| 21 |
Foreword
|
|
|
2013
|
|
2-3 |
p. 75-76
|
article
|
| 22 |
Four editorial proposals to improve social sciences research and publication
|
Jay Joseph
|
|
2001
|
|
2-3 |
p. 109-116
|
article
|
| 23 |
From knowledge to action: improving drug safety
|
|
|
2013
|
|
2-3 |
p. 195-209
|
article
|
| 24 |
Health foods or healthy foodsAthens, 22–24 November 1990
|
|
|
2013
|
|
2-3 |
p. 161-164
|
article
|
| 25 |
Hippocrates
|
|
|
2001
|
|
2-3 |
p. 183-185
|
article
|
| 26 |
Information for Authors
|
|
|
2013
|
|
2-3 |
p. 169-170
|
article
|
| 27 |
Interactions between herbal medicinal products and synthetic drugs
|
|
|
2001
|
|
2-3 |
p. 77-79
|
article
|
| 28 |
IntroductionPharmacovigilance: what is it? why does it exist?
|
|
|
2013
|
|
2-3 |
p. 77-84
|
article
|
| 29 |
Is risk management necessary?
|
Dingwall, Robert
|
|
2013
|
|
2-3 |
p. 91-106
|
article
|
| 30 |
Legal implications of discrimination in medical practice
|
Jessamyn S. Berniker
|
|
2001
|
|
2-3 |
p. 129-133
|
article
|
| 31 |
Norway: Patient Compensation Council
|
|
|
2001
|
|
2-3 |
p. 179-181
|
article
|
| 32 |
Oslo statement
|
|
|
2001
|
|
2-3 |
p. 175-176
|
article
|
| 33 |
Patient rights versus patent rights
|
|
|
2001
|
|
2-3 |
p. 135-136
|
article
|
| 34 |
Patient versus patent rights
|
Zweli Mkhize
|
|
2001
|
|
2-3 |
p. 167-173
|
article
|
| 35 |
Pharmaco-epidemiological approaches to the study of signals
|
|
|
2013
|
|
2-3 |
p. 167-193
|
article
|
| 36 |
Prescription drugs: Direct advertising?
|
|
|
2001
|
|
2-3 |
p. 81-86
|
article
|
| 37 |
Prices and access to essential medicines
|
Carl-Erik Schulz
|
|
2001
|
|
2-3 |
p. 143-151
|
article
|
| 38 |
Psychiatric drugs for infants and toddlers: Treatment or crime?
|
|
|
2001
|
|
2-3 |
p. 87-90
|
article
|
| 39 |
Reviews of books and studies
|
|
|
2013
|
|
2-3 |
p. 165-167
|
article
|
| 40 |
Risk management: a practical approach
|
|
|
2013
|
|
2-3 |
p. 63
|
article
|
| 41 |
Risk management implementation programmes
|
Roberts, Geoffrey
|
|
2013
|
|
2-3 |
p. 141-143
|
article
|
| 42 |
Risk management in anaesthesia
|
Aitkenhead, A.R.
|
|
2013
|
|
2-3 |
p. 113-123
|
article
|
| 43 |
Risk management in obstetrics and gynaecology
|
James, Catherine E.
|
|
2013
|
|
2-3 |
p. 133-140
|
article
|
| 44 |
Risk management in surgery
|
Smith, Joseph C.
|
|
2013
|
|
2-3 |
p. 125-128
|
article
|
| 45 |
Risk management in trauma and orthopaedics
|
Vickers, Roger
|
|
2013
|
|
2-3 |
p. 107-111
|
article
|
| 46 |
Safety and risk in practice
|
|
|
2001
|
|
2-3 |
p. 191-193
|
article
|
| 47 |
Screening for human T-cell lymphotrophic virus type I (HTLV-I) infection in Jewish psychiatric patients of Iranian origin
|
B. Spivak
|
|
2001
|
|
2-3 |
p. 95-98
|
article
|
| 48 |
Signal detection by spontaneous reporting
|
|
|
2013
|
|
2-3 |
p. 91-104
|
article
|
| 49 |
The drug safety crisis
|
|
|
2013
|
|
2-3 |
p. 211-222
|
article
|
| 50 |
The Finnish patient insurance and compensation scheme
|
|
|
2001
|
|
2-3 |
p. 195-197
|
article
|
| 51 |
The physician's civil liability under Danish law
|
Fenger, Niels
|
|
2013
|
|
2-3 |
p. 65-82
|
article
|
| 52 |
The risks of obstetrics and gynaecology in practice
|
Chamberlain, Geoffrey
|
|
2013
|
|
2-3 |
p. 129-132
|
article
|
| 53 |
Unaffordable medicine pricing: Brazil's experience
|
Maria Fernanda Macedo
|
|
2001
|
|
2-3 |
p. 163-166
|
article
|
| 54 |
Unwanted outcomes of drug treatment and their study
|
|
|
2013
|
|
2-3 |
p. 85-89
|
article
|
| 55 |
What is risk management?
|
Hill, Garth
|
|
2013
|
|
2-3 |
p. 83-90
|
article
|
Journal description